Cholangiocarcinoma |
Phase 2 |
ClinicalTrials |
Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms |
Phase 2 |
ClinicalTrials |
Lymphoma, T-Cell |
Phase 1/Phase 2 |
ClinicalTrials |
Thyroid Diseases; Thyroid Neoplasms |
Phase 2 |
ClinicalTrials |
Esophageal Neoplasms |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2/Phase 3 |
ClinicalTrials |
Sarcoma |
Phase 2 |
ClinicalTrials |
Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Neoplasms, Squamous Cell |
Phase 2 |
ClinicalTrials |
Lung Neoplasms; Small Cell Lung Carcinoma |
Phase 2 |
ClinicalTrials |
Lung Neoplasms; Small Cell Lung Carcinoma |
Phase 2 |
ClinicalTrials |
Sarcoma |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 1 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung |
Phase 2 |
ClinicalTrials |
Carcinoma; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms |
Phase 3 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 2 |
ClinicalTrials |
Melanoma |
Phase 2 |
ClinicalTrials |
Uterine Cervical Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung |
Phase 2 |
ClinicalTrials |
Breast Neoplasms; Triple Negative Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Breast Neoplasms; Triple Negative Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 2 |
ClinicalTrials |
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms |
Phase 2 |
ClinicalTrials |
Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms |
Phase 2 |
ClinicalTrials |
Uterine Cervical Neoplasms |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Colorectal Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
Phase 3 |
ClinicalTrials |
Ascites |
Phase 2 |
ClinicalTrials |
Breast Neoplasms; Carcinoma, Ovarian Epithelial; Ovarian Neoplasms; Triple Negative Breast Neoplasms |
Phase 1 |
ClinicalTrials |
Breast Neoplasms; Triple Negative Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms |
Phase 2 |
ClinicalTrials |
Melanoma |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 2 |
ClinicalTrials |
Adenocarcinoma |
Phase 1 |
ClinicalTrials |
Colorectal Neoplasms |
Phase 2 |
ClinicalTrials |
Biliary Tract Neoplasms; Carcinoma |
Phase 2 |
ClinicalTrials |
Pancreatic Neoplasms |
Phase 2 |
ClinicalTrials |
Gestational Trophoblastic Disease |
Phase 2 |
ClinicalTrials |
Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Glioma |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung |
Phase 2 |
ClinicalTrials |
Breast Neoplasms; Triple Negative Breast Neoplasms |
Phase 1/Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 1/Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Neoplasms; Ovarian Neoplasms; Stomach Neoplasms |
Phase 4 |
ClinicalTrials |
Adenocarcinoma; Adenocarcinoma of Lung |
Phase 2 |
ClinicalTrials |
Glioma |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
Phase 4 |
ClinicalTrials |
Carcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma |
Phase 2 |
ClinicalTrials |
Adenocarcinoma; Carcinoma, Transitional Cell; Neoplasms |
Phase 1/Phase 2 |
ClinicalTrials |
Lymphoma; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral |
Phase 4 |
ClinicalTrials |
Colorectal Neoplasms |
Phase 2 |
ClinicalTrials |
Esophageal Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma; Liver Neoplasms |
Phase 2 |
ClinicalTrials |
Esophageal Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 2 |
ClinicalTrials |
Adenocarcinoma |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 3 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 3 |
ClinicalTrials |
Stomach Neoplasms |
Phase 3 |
ClinicalTrials |
Adenocarcinoma |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
Phase 1/Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Squamous Cell |
Phase 4 |
ClinicalTrials |
Adenocarcinoma |
Phase 1 |
ClinicalTrials |
Pancreatic Neoplasms |
Phase 2 |
ClinicalTrials |
Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Colorectal Neoplasms |
Phase 3 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular; Stomach Neoplasms |
Phase 1/Phase 2 |
ClinicalTrials |
Bile Duct Neoplasms; Carcinoma |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 3 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung |
Phase 3 |
ClinicalTrials |
Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Neoplasms, Squamous Cell |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
Phase 2 |
ClinicalTrials |
Lung Neoplasms |
Phase 2 |
ClinicalTrials |
Adenocarcinoma; Adenocarcinoma of Lung |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Signet Ring Cell; Stomach Neoplasms |
Phase 3 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma |
Phase 1 |
ClinicalTrials |
Thyroid Diseases; Thyroid Neoplasms |
Phase 2 |
ClinicalTrials |
Breast Neoplasms; Triple Negative Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Neoplasm Metastasis; Osteosarcoma |
Phase 2 |
ClinicalTrials |
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms |
Phase 2 |
ClinicalTrials |
Lung Neoplasms; Small Cell Lung Carcinoma |
Phase 3 |
ClinicalTrials |
Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse |
Phase 4 |
ClinicalTrials |
Breast Neoplasms; Triple Negative Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 3 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung |
Phase 2 |
ClinicalTrials |
Osteosarcoma; Sarcoma |
Phase 2 |
ClinicalTrials |
Breast Neoplasms |
Phase 2/Phase 3 |
ClinicalTrials |
Neoplasms; Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Adenocarcinoma; Adenocarcinoma of Lung |
Phase 2 |
ClinicalTrials |
Adenocarcinoma; Stomach Neoplasms |
Phase 1/Phase 2 |
ClinicalTrials |
Lung Neoplasms; Small Cell Lung Carcinoma |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 4 |
ClinicalTrials |
Drug-Related Side Effects and Adverse Reactions |
Phase 4 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 2 |
ClinicalTrials |
Esophageal Neoplasms; Metaplasia |
Phase 2/Phase 3 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Head and Neck Neoplasms |
Phase 2 |
ClinicalTrials |
Esophageal Neoplasms; Recurrence |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Neoplasm Metastasis; Neoplasms, Second Primary; Recurrence |
Phase 2 |
ClinicalTrials |
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2/Phase 3 |
ClinicalTrials |
Adenocarcinoma |
Phase 2 |
ClinicalTrials |
Cholangiocarcinoma |
Phase 2 |
ClinicalTrials |
Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Neoplasm Metastasis; Osteosarcoma |
Phase 2/Phase 3 |
ClinicalTrials |
Lung Neoplasms; Small Cell Lung Carcinoma |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2/Phase 3 |
ClinicalTrials |
Small Cell Lung Carcinoma |
Phase 2 |
ClinicalTrials |
Carcinoma; Nasopharyngeal Carcinoma |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Adenoid Cystic |
Phase 2 |
ClinicalTrials |
Ovarian Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma; Carcinoma, Renal Cell |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Osteosarcoma |
Phase 2 |
ClinicalTrials |
Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma |
Phase 2 |
ClinicalTrials |
Esophageal Neoplasms |
Phase 2 |
ClinicalTrials |
Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Biliary Tract Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
Phase 3 |
ClinicalTrials |
Carcinoma |
Phase 2 |
ClinicalTrials |
Breast Neoplasms; Triple Negative Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Lung Diseases; Neoplasms; Respiratory Tract Diseases; Thoracic Neoplasms |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Adenocarcinoma; Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Head and Neck Neoplasms |
Phase 1/Phase 2 |
ClinicalTrials |
Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary |
Phase 2/Phase 3 |
ClinicalTrials |
Breast Neoplasms |
Phase 2 |
ClinicalTrials |
Thyroid Neoplasms |
Phase 2 |
ClinicalTrials |
Digestive System Neoplasms; Gastrointestinal Neoplasms; Neoplasms; Stomach Diseases; Stomach Neoplasms |
Phase 3 |
ClinicalTrials |
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma; Gallbladder Neoplasms |
Phase 2 |
ClinicalTrials |
Pancreatic Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Sarcoma |
Phase 2 |
ClinicalTrials |
Stomach Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
Phase 2 |
ClinicalTrials |
Adenocarcinoma; Stomach Neoplasms |
Phase 3 |
ClinicalTrials |
Head and Neck Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung |
Phase 2 |
ClinicalTrials |
Colorectal Neoplasms |
Phase 2 |
ClinicalTrials |
Adenocarcinoma |
Phase 2 |
ClinicalTrials |
Colorectal Neoplasms |
Phase 2 |
ClinicalTrials |
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
Phase 2/Phase 3 |
ClinicalTrials |
Carcinoma; Carcinoma, Hepatocellular |
Phase 2 |
ClinicalTrials |